Clinical Trial Update: Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc) [NA]

View source ↗

Summary

A clinical trial evaluating pulmonary Doppler signals in patients with Systemic Sclerosis and Pulmonary Hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Systemic Sclerosis

Snippet

Sponsor: Echosense Ltd. | Conditions: Systemic Sclerosis, Pulmonary Hypertension | NA | Status: WITHDRAWN